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Introduction
Chronic constipation (CC) is a very common condition not
only in children but also in adults. Intestinal neuronal dyspla-
sia (IND), a condition with specific histopathological signs,
has symptoms and signs typical of CC and usually presents as
chronic intractable constipation, abdominal distension and
overflow incontinence in childhood.1 There are few reports in
adults.2,3 In general, the pathophysiology of CC, including
IND, is incompletely understood.
Mucosal Neuroendocrine Cell Abnormalities in Patients
with Chronic Constipation
In the gut, polypeptides are produced by neuroendocrine
cells (NEC) diffusely present throughout the gut mucosa and
the neurons of the enteric nervous system.4 The neural and
endocrine systems should be considered as a single entity,
both interacting constantly with each other. Thus, NEC modu-
late gut function by endocrine, paracrine or neurocrine
routes.5 In particular, paracrine and neurocrine modes of
action are of importance in the gut and may act as additional
control systems.5 Intrinsic mucosal innervation, which has a
direct morphological relationship with NEC, originates in
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submucosal ganglia.6 Colonic NEC produce endocrine/
paracrine peptides that play an important role in regulating
large-intestinal motility, absorption and secretion.7,8
Chromogranin-A (Ch-A) is a marker for NEC. It is a large,
soluble protein originally purified from bovine adrenal me-
dulla where it appears to be stored and released together with
catecholamines. More recent studies have revealed that Ch-A
is present in polypeptide-producing human tumours as well as
in normal endocrine tissues, including the endocrine cells
of the gut. Although the functions of Ch-A have yet to be
fully established, it is thought to stabilize the intragranular
complex.9
Another marker for NEC, 5-hydroxytryptamine (serotonin,
5-HT), can be identified using a specific marker amine. 5-HT
can stimulate contraction of jejunal longitudinal smooth
muscle; activation of mast cells results in muscle contraction
in vitro, mainly through the release of 5-HT.10
The clinical history and presentation of IND can be similar
to Hirschsprung’s disease, in which there is a known abnormal
distribution of NEC in the gut, as well as a change in the
distribution of types of NEC.8 IND is purported to be a
congenital malformation of gastrointestinal innervation
caused by dysplastic embryonal development of the enteric
nervous system. In fact, in affected aganglionic segments,
there are markedly increased numbers of NEC compared with
ganglionic and normal specimens.11 Although Hirschsprung’s
disease has been studied intensively, to the best of our
knowledge, there have been no reports on the relationships
among NEC, CC and IND.
In this study, we visualized NEC in the rectal mucosa from
CC patients, including IND patients, using monoclonal anti-
bodies to Ch-A and 5-HT. In addition, we assessed the distribu-
tion of NEC at different clinical stages of illness, comparing
the results with those obtained from normal controls.
Patients and methods
Rectal biopsies were taken from 43 patients (age, 17–82 years;
17 men and 26 women) with CC attending our outpatient
clinic between 1 January 1996 and 31 December 2000. Rectal
biopsies taken from 20 patients (age, 30–73 years; 8 men and
12 women) during routine colonoscopy were used as controls.
At our institution, we usually take two rectal biopsies 3 cm
above the dentate line from each subject. All rectal biopsies
were performed using the same technique with the Gruenwald’s
nasal cutting forceps method without general anaesthesia.12
Biopsies were used to assess the structure of the submu-
cosal ganglia to diagnose IND and exclude Hirschsprung’s
disease and other allied disorders. The criteria used to diag-
nose IND were hyperganglionosis of the submucosal plexus,
presence of giant ganglia, and at least one of the following:
presence of ectopic ganglia or increased numbers of acetylcho-
linesterase (AchE)-positive nerve fibres around submucosal
blood vessels or in the lamina propria.
Management of CC was used to classify our subjects.
Those managed invasively were further classified according to
histopathologic findings.
All subjects were investigated after obtaining informed
consent to participate in this study. The study was approved by
the Juntendo University School of Medicine Ethics Committee,
and complied with the Helsinki Declaration of 1975 (revised
1983).
Tissue preparation
All biopsy specimens were fixed in 10% phosphate-buffered
formalin and embedded in paraffin wax and snap-frozen.
Tissue for haematoxylin-eosin staining and AchE studies was
sectioned conventionally. Tissue to be stained immunohis-
tochemically was sectioned into 5 µm thick sections, de-
paraffinized, and treated with hydrogen peroxide to block
endogenous peroxidase activity. Sections were then incubated
for 24 hours with primary antibodies against Ch-A (1:10
dilution; Dako, Tokyo, Japan) and 5-HT (1:20 dilution; Dako).
After incubation with a biotinylated secondary antibody, sec-
tions were reacted with an avidin-biotin peroxidase complex
(ABC, Dako), stained with 3,3’-diaminobenzidine and hydro-
gen peroxide, and counter-stained with 1% methyl green solu-
tion (pH 4.0). To provide a negative control in immunohisto-
chemical studies, the primary antibody was omitted.
Quantification
Quantification of results was carried out on perpendicularly
oriented sections of rectal mucosa. The numbers of Ch-A and
5-HT immunoreactive cells per visual field were counted, and
the number of positive NEC per 70 crypts (CR) expressed as a
ratio, NEC/CR. The mean, standard deviation and standard
error were calculated for each group, and Student’s t test was
used to test differences between results from each group and
the control group.
Results
Chronic constipation was managed conservatively in 29 pa-
tients (group A) and invasively in 14. On haematoxylin-eosin
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and AchE staining, group A and 10 of the 14 cases managed
invasively (group B) showed normal morphology of submu-
cosal ganglia and no increased AchE activity in the mucosal
layer. Four of the cases managed invasively had hyperplasia of
submucosal plexuses and giant ganglia or ectopic ganglia or
increased AchE activity in the mucosal layer, and were diag-
nosed with IND (group C). All control specimens were un-
remarkable.
Medical records showed that group A was managed con-
servatively with laxatives and enemas. Group B required myec-
tomy and group C required surgical intervention such as
myectomy or pull-through because of resistance to long-term
conservative treatment (Table).
On immunohistochemical staining, the numbers of Ch-A
(Figure 1) and 5-HT (Figure 2) immunoreactive cells were
significantly increased in the lamina propria of the rectal
mucosa in group B (NEC/CR: 2.79 ± 0.18 and 1.72 ± 0.33,
respectively) and group C (NEC/CR: 3.12 ± 0.22 and 2.32 ±
0.14, respectively) compared with controls (NEC/CR: 0.94 ±
0.33 and 0.32 ± 0.08, respectively; p < 0.001 and p < 0.05). In
group A, Ch-A and 5-HT immunoreactive cells were signi-
ficantly increased (NEC/CR: 2.23 ± 0.13 and 1.02 ± 0.06)
compared with controls (p < 0.001 and p < 0.05), but less so
than in group B (Figures 3 and 4).
Discussion
Patients with CC have a variety of underlying pathologies that
result in poor gut motility.13 However, the mechanisms of
Table. Histological data including treatment regimens for patients in groups B and C.
Case Group Histology Diagnosis AchE activity Treatment
1 C Abnormal IND – Pull-through
2 C Abnormal IND – Myectomy
3 C Abnormal IND + Pull-through
4 C Abnormal IND – Myectomy
5 B Normal CC – Myectomy
6 B Normal CC – Myectomy
7 B Normal CC – Myectomy
8 B Normal CC – Myectomy
9 B Normal CC – Myectomy
10 B Normal CC – Myectomy
11 B Normal CC – Myectomy
12 B Normal CC – Myectomy
13 B Normal CC – Myectomy
14 B Normal CC – Myectomy
AchE = acetylcholinesterase; IND = intestinal neuronal dysplasia; CC = chronic constipation; – = negative; + = positive.
Figure 1. A) Numerous chromogranin-A (Ch-A) immunoreactive
cells in rectal mucosal crypts from a patient with chronic constipa-
tion (magnification × 200); B) small number of Ch-A immunoreac-
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Figure 4. Epithelial 5-hydroxytryptamine immunoreactive neuroen-
docrine cells in chronic constipation (groups A and B) and intestinal
neuronal dysplasia (group C) versus normal controls.
Figure 2. A) Numerous 5-hydroxytryptamine (5-HT) immunoreac-
tive cells in rectal mucosal crypts from a patient with chronic
constipation (magnification × 200); B) small number of 5-HT
immunoreactive cells in rectal mucosal crypts from a normal con-
trol (magnification × 200).
Figure 3. Epithelial chromogranin-A immunoreactive neuroendo-
crine cells in chronic constipation (groups A and B) and intestinal
neuronal dysplasia (group C) versus normal controls.
abnormal bowel function are poorly understood. Most people
have a bowel movement between three times a day and once
every 3 days, but in CC patients, constipation may be very
severe, with bowel motions every 2 to 3 weeks associated with
distension and discomfort.13 Patients with IND also have
symptoms of constipation, abdominal distension and
megacolon, but have distinct histopathological signs that
distinguish them from idiopathic cases of constipation.1
In the present study, the entire gut distribution of NEC
was examined in tissue sections from patients with CC and
IND using antibodies to Ch-A and 5-HT. Furthermore, in
order to obtain more information on the relationship between
the course of the disease (histological abnormalities and ne-
cessity for surgery) and changes in NEC, three separate groups
of CC (including IND) were examined and compared with age-
matched normal controls.
We found a significant increase in enteric NEC in IND and
CC compared with normal controls. The most interesting
finding was that the increase in NEC was greater in IND and
clinically severe cases of CC requiring surgery than in cases of
CC who could be managed conservatively, suggesting that the
distribution of NEC is implicated in the aetiology of bowel
function. In IND in particular, not only is the NEC population
affected in number, but there are also morphological changes
in the NEC such as giant ganglia and hyperplasia of submu-
cosal plexuses. Similarly, colonic nodular NEC hyperplasia
with formation of acini is known to be associated with
megacolon,14 which further supports our findings with regard
to IND.
The mechanism of how increased numbers of NEC con-
tribute to constipation and colonic dysmotility is still not
clear, but our study shows that there is a definitive difference
in NEC in patients with CC and IND. 5-HT is known to
stimulate contraction of smooth muscle layers of the bowel;
increased numbers of 5-HT-positive NEC in the rectal mucosa
of patients with CC and IND could result in excessive amounts
A
B
Normal A B C
p < 0.001
p < 0.001























Normal A B C
p < 0.05
p < 0.05
p < 0.05 p < 0.05
ASIAN JOURNAL OF SURGERY  VOL 27 • NO 3 • JULY 2004 201
070/2001
■ MUCOSAL NEUROENDOCRINE CELL ABNORMALITIES ■
of 5-HT. Further studies on the action of substances produced
by NEC are required.
We conclude that these results demonstrate that increased
numbers of NEC may play a role in the abnormal bowel
function seen in CC and IND, and that they could develop
into, or progress to form, giant ganglia in the submucosa in
IND cases.
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